SCHEMBL22370925

SCHEMBL22370925

C[C@@H](c1nnn[nH]1)N(Cc1ccccc1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ATM Q13315 1/20 0.43
LMNA P02545 2/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
HSD17B10 Q99714 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HPGD P15428 1/20 0.39
OPRD1 P41143 2/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14910876 0.84 MEN1 (0.43) MEN1KMT2AATMLMNAALDH1A1
SCHEMBL10822154 0.81 MEN1 (0.39) MEN1KMT2AATMLMNAALDH1A1
SCHEMBL347414 0.79 MEN1 (0.47) MEN1KMT2AATMLMNAALDH1A1
SCHEMBL1701279 0.72 KMT2A (0.76) MEN1KMT2AATMLMNAALDH1A1
SCHEMBL24884476 0.71 ATM (0.48) KMT2AATMALDH1A1HSD17B10L3MBTL1
SCHEMBL22370926 0.70 ATM (0.67) ATM
SCHEMBL22370927 0.70 ATM (0.67) ATM
SCHEMBL2093344 0.70 CYP1A2 (0.39)
SCHEMBL19349131 0.70 MEN1 (0.61) MEN1KMT2AATMLMNAALDH1A1
SCHEMBL4955854 0.70 MEN1 (0.61) MEN1KMT2AATMLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3687988-B1 ANTIBACTERIAL COMPOUND AND USES OF SAME BIOMERIEUX SA (FR) 2023-05-03 EP disclosed
US-11414403-B2 Antibacterial compound and uses of same BIOMERIEUX (FR) 2022-08-16 US disclosed
US-20200277281-A1 ANTIBACTERIAL COMPOUND AND USES OF SAME bioMérieux (FR) 2020-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200277281-A1 ANTIBACTERIAL COMPOUND AND USES OF SAME GLUL, PGLS, TGM3 MEN1 2096/4885KMT2A 2579/4885ATM 4551/4885
US-11414403-B2 Antibacterial compound and uses of same GLUL, PGLS, TGM3 MEN1 2096/4885KMT2A 2579/4885ATM 4551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.